CorMedix (CRMD) Free Cash Flow (2010 - 2025)

CorMedix (CRMD) has 15 years of Free Cash Flow data on file, last reported at $92.7 million in Q4 2025.

• For the quarter ending Q4 2025, Free Cash Flow rose 1748.72% year-over-year to $92.7 million; the trailing twelve-month figure through Dec 2025 stood at $172.8 million (up 440.59% YoY), and the FY2025 full-year result was $172.8 million, up 440.59% from the prior year.
• Free Cash Flow rose to $92.7 million in Q4 2025, from $30.4 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $92.7 million in Q4 2025 to a low of -$17.4 million in Q1 2024.
• A 5-year average of $1.8 million and a median of -$6.4 million in 2021 frame the typical range for Free Cash Flow.
• Across the five-year window, Free Cash Flow slumped 308.37% in 2021 and jumped 1748.72% in 2025, its largest moves.
• Tracing CRMD's Free Cash Flow over 5 years: stood at -$6.5 million in 2021, then rose by 3.3% to -$6.3 million in 2022, then slumped by 75.72% to -$11.0 million in 2023, then soared by 49.06% to -$5.6 million in 2024, then jumped by 1748.72% to $92.7 million in 2025.
• Business Quant data shows CRMD's Free Cash Flow at $92.7 million in Q4 2025, $30.4 million in Q3 2025, and $30.0 million in Q2 2025.